Marine Origin Polymers as Biomaterials for Bioprinting
A special issue of Marine Drugs (ISSN 1660-3397).
Deadline for manuscript submissions: closed (10 February 2022) | Viewed by 6917
Special Issue Editor
2. 3D Immune System Imaging Core Center, Ajou University, Suwon 16499, Republic of Korea
3. Immune-Network Pioneer Research Center, Ajou University Medical Center, Suwon 16499, Republic of Korea
Interests: 3D culture; immune microenvironment; functional polymer
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Bioprinting is a three-dimensional (3D) fabrication technology used to deposit cell-laden hydrogen bioinks for the fabrication of functional living tissues. Importantly, 3D bioprinting enables certain tissue engineering applications of the printed tissue or organ for replacements of diseased or damaged organs in patients. Natural and synthetic hydrogels in bioprinting require physical and biological properties to mimic extracellular matrix in tissues. Natural polymers from marine resources, including alginate, collagen, hyaluronic acid, and chitosan, are biologically active and abundant compared to polymers from other resources. Biopolymers from marine resources, including fish, algae, bacteria, and fungi, can be used as a bioink in 3D bioprinting. However, the number of marine materials suitable for 3D bioprinting has been limited for the development of 3D printing materials. This Special Issue aims to provide an overview of the current research in isolation processes, physical or chemical modifications, and hydrogel formation of marine biomaterials for bioprinting. As Guest Editor of this Special Issue, I cordially invite contributions in the form of original research articles or reviews on the subject of this interesting research field.
Prof. Dr. Jong-Young Kwak
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Marine Drugs is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- bioprinting
- biofabrication
- biopolymers
- organoids
- 3D cell printing
- bioink
- tissue engineering
- hydrogel
- gelation
